Form D · Other

Wesana Health Holdings Inc

Chicago, IL · CIK 0001882836

Offering snapshot reported May 6, 2022 · SEC filing

Reported sold
$486K
Offering amount: $1.08M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 2, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 6, 2022Initial$485,670No comparison5SEC filing
Sep 23, 2021Initial$0No comparison1SEC filing
Sep 23, 2021Initial$0No comparison39SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-444881
"Total Remaining to be Sold" is the aggregate purchase price of shares underlying warrants sold in this offering. U.S. dollar amounts are based on the Bank of Canada exchange rate 0.7755 reported on May 2, 2022.
Each Unit consists of 1 cm sh & 1 wrt. Each wrt entitles the holder to purchase 1 wrt sh at a price of CDN$45.00 for a period of 3 years following the closing date

Source: Form D, filed May 6, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Chad Bronstein Director, Executive
Ian Burnstein Director
Daniel Carcillo Director, Executive
Meghna Gaeta Executive
Mitchell Kahn Director
Robert Koffman Director
Israel Mirsky Executive
Dr. Abid Nazeer Executive
Hayim Raclaw Executive
George Iv Steinbrenner Director
Zed Wang Executive
Mark Wingertzahn Executive
Mark Ph D. Wingertzahn Executive

Issuer details

Industry: Other (See others in industry)

Address:
433 W Van Buren St. Suite 200
Chicago, IL, 60607